Who owns GreyWolf Therapeutics?

GreyWolf Therapeutics is currently owned by Andera Partners, through BioDiscovery 5, since 2018.

When did Andera Partners acquire GreyWolf Therapeutics?

Andera Partners acquired GreyWolf Therapeutics in 2018 (active for 8 years).

Home/Companies/Healthcare/GreyWolf Therapeutics

GreyWolf Therapeutics

Healthcare·

UK·Active·8yr hold

GreyWolf Therapeutics is a healthcare company, headquartered in United Kingdom.

Entry

2018

Hold

8yr

Status

Active

Est. EV

–

Investor

Andera Partners

Key facts

HQUnited Kingdom

SectorHealthcare

Small molecules to increase tumor detection by the immune system

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from BioDiscovery 5

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings